Search

Your search keyword '"Ratone, Jean Philippe"' showing total 168 results
Start Over Author "Ratone, Jean Philippe"
168 results on '"Ratone, Jean Philippe"'

3. In vivo organoid growth monitoring by stimulated Raman histology

Author

Sarri, Barbara, Chevrier, Véronique, Poizat, Flora, Heuke, Sandro, Franchi, Florence, De Franqueville, Louis, Traversari, Eddy, Ratone, Jean-Philippe, Caillol, Fabrice, Dahel, Yanis, Hoibian, Solène, Giovannini, Marc, de Chaisemartin, Cécile, Appay, Romain, Guasch, Géraldine, and Rigneault, Hervé

Published
2024
Full Text
View/download PDF

4. Endoscopic papillectomy for ampullary lesions of minor papilla

Author

Vu Trung, Kien, Heise, Christian, Abou-Ali, Einas, Auriemma, Francesco, Karam, Elias, van der Wiel, Sophia E., Bruno, Marco J., Caillol, Fabrice, Giovannini, Marc, Masaryk, Viliam, Will, Uwe, Anderloni, Andrea, Pérez-Cuadrado-Robles, Enrique, Dugic, Ana, Meier, Benjamin, Paik, Woo H., Petrone, Maria C., Wichmann, Dörte, Dinis-Ribeiro, Mario, Gonçalves, Tiago C., Wedi, Edris, Schmidt, Arthur, Gulla, Aiste, Hoffmeister, Albrecht, Rosendahl, Jonas, Ratone, Jean Philippe, Saadeh, Rita, Repici, Alessandro, Deprez, Pierre, Sauvanet, Alain, Souche, Francois R., Fabre, Jean M., Muehldorfer, Steffen, Caca, Karel, Löhr, Matthias, Michl, Patrick, Krug, Sebastian, Regner, Sara, Gaujoux, Sebastien, and Hollenbach, Marcus

Published
2024
Full Text
View/download PDF

5. Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial

Author

Corre, Félix, Albouys, Jérémie, Tran, Viet-Thi, Lepilliez, Vincent, Ratone, Jean-Philippe, Coron, Emmanuel, Lambin, Thomas, Rahmi, Gabriel, Karsenti, David, Canard, Jean-Marc, Chabrun, Edouard, Camus, Marine, Wallenhorst, Timothée, Chevaux, Jean-Baptiste, Schaefer, Marion, Gerard, Romain, Cappelle, Elisabeth, Rouquette, Alexandre, Terris, Benoit, Coriat, Romain, Jacques, Jérémie, Barret, Maximilien, Pioche, Mathieu, and Chaussade, Stanislas

Published
2024
Full Text
View/download PDF

10. Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort THE for locally advanced GEJC

Author

Meillat Hélène, Niziers Vincent, Zemmour Christophe, Ewald Jacques, Ratone Jean-Philippe, Dermeche Slimane, and Guiramand Jérôme

Subjects
Esophageal neoplasms, Neoadjuvant therapy, Esophagectomy, Survival, Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background and purpose To report the postoperative and oncological outcomes of transhiatal esophagectomy for locally advanced cancer of the gastroesophageal junction. Methods Medical records of 120 consecutive patients who underwent transhiatal esophagectomy for locally advanced cancer of the gastroesophageal junction with curative intent after neoadjuvant treatment between February 2006 and December 2018 at our center were reviewed. Results All patients received either chemotherapy (46.7%) or chemoradiation (53.3%). The 90-day mortality and overall morbidity rates were 0.8% and 56.7%, respectively. Respiratory complications were the most common (30.8%). Anastomotic leakage occurred in 19 patients (15.8%), who were treated by local wound care (n = 13) or surgical drainage (n = 6). Recurrent laryngeal nerve injury occurred in 12 patients (9.9%). The median length of hospital stay was 15.5 days. The rate of R0 resection was 95.8%, and the median number of nodes removed was 17.5. Over a median follow-up of 77 months, the rate of recurrence was 40.8%, and the overall survival rates at 1, 3, and 5 years were 91%, 75%, and 65%, respectively. The median survival time was not reached. In multivariate analysis, disease stage was the only independent significant prognostic factor. Conclusions Transhiatal esophagectomy is a safe and effective procedure with good long-term oncological outcomes for locally advanced tumors after neo-adjuvant treatment. It can be recommended for all patients with cancer of the gastroesophageal junction, regardless of the Siewert classification, tumor stage, and comorbidities.

Published
2022
Full Text
View/download PDF

14. Endoscopic Papillectomy for Ampullary Lesions of minor papilla

Author

Trung, Kien Vu, primary, Heise, Christian, additional, Abou-Ali, Einas, additional, Auriemma, Francesco, additional, Karam, Elias, additional, van der Wiel, Sophia E., additional, Bruno, Marco J., additional, Caillol, Fabrice, additional, Giovannini, Marc, additional, Masaryk, Viliam, additional, Will, Uwe, additional, Anderloni, Andrea, additional, Pérez-Cuadrado-Robles, Enrique, additional, Dugic, Ana, additional, Meier, Benjamin, additional, Paik, Woo H., additional, Petrone, Maria C., additional, Wichmann, Dörte, additional, Dinis-Ribeiro, Mario, additional, Gonçalves, Tiago C., additional, Wedi, Edris, additional, Schmidt, Arthur, additional, Gulla, Aiste, additional, Hoffmeister, Albrecht, additional, Rosendahl, Jonas, additional, Ratone, Jean Philippe, additional, Saadeh, Rita, additional, Repici, Alessandro, additional, Deprez, Pierre, additional, Sauvanet, Alain, additional, Souche, Francois R., additional, Fabre, Jean M., additional, Muehldorfer, Steffen, additional, Caca, Karel, additional, Löhr, Matthias, additional, Michl, Patrick, additional, Krug, Sebastian, additional, Regner, Sara, additional, Gaujoux, Sebastien, additional, and Hollenbach, Marcus, additional

Published
2023
Full Text
View/download PDF

15. Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial

Author

CORRE, Félix, primary, ALBOUYS, Jérémie, additional, TRAN, Viet-Thi, additional, LEPILLIEZ, Vincent, additional, RATONE, Jean-Philippe, additional, CORON, Emmanuel, additional, LAMBIN, Thomas, additional, RAHMI, Gabriel, additional, KARSENTI, David, additional, CANARD, Jean-Marc, additional, CHABRUN, Edouard, additional, CAMUS, Marine, additional, WALLENHORST, Timothée, additional, CHEVAUX, Jean-Baptiste, additional, SCHAEFER, Marion, additional, GERARD, Romain, additional, ROUQUETTE, Alexandre, additional, TERRIS, Benoit, additional, CORIAT, Romain, additional, JACQUES, Jérémie, additional, BARRET, Maximilien, additional, PIOCHE, Mathieu, additional, and CHAUSSADE, Stanislas, additional

Published
2023
Full Text
View/download PDF

16. Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French Center

Author

Ratone, Jean-Philippe, primary, Archimbaud, Clément, primary, Solovyev, Alexey, primary, Zemmour, Christophe, primary, Pesenti, Christian, primary, Hoibian, Solène, primary, Dahel, Yanis, primary, Marx, Mariola, primary, De Chaisemartin, Cécile, primary, Chanez, Brice, primary, Meillat, Hélène, primary, Lelong, Bernard, primary, Poizat, Flora, primary, Caillol, Fabrice, primary, and Giovannini, Marc, primary

Published
2023
Full Text
View/download PDF

18. Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a singlecenter observational study.

Author

Marx, Mariola, Caillol, Fabrice, Godat, Sébastien, Poizat, Flora, Oumrani, Sarra, Ratone, Jean-Philippe, Hoibian, Solène, Dahel, Yanis, Oziel-Taieb, Sandrine, Niccoli, Patricia, Ewald, Jacques, Mitry, Emmanuel, and Giovannini, Marc

Subjects
PANCREATIC tumors, NEUROENDOCRINE tumors, SURGICAL excision, PANCREATIC surgery, PANCREATIC duct, LYMPHATIC metastasis, PANCREATICODUODENECTOMY
Abstract

Background: Current guidelines consider observation a reasonable strategy for G1 or G2 nonfunctional pancreatic neuroendocrine tumors (nf pNETs) =2 cm. We aimed to characterize their natural behavior and confront the data with the outcomes of patients undergoing upfront surgery. Methods: Data from patients with histologically confirmed nf pNETs =2 cm, managed at a single tertiary referral center between 2002 and 2020, were retrospectively reviewed. Results: Thirty-nine patients (mean age 62.1 years, 56% male) with 43 lesions (mean size 12.7±3.9 mm; 32 grade 1 [G1] and 7 grade 2 lesions [G2]) were managed by careful surveillance. Progression was observed in 15 lesions (35%; mean follow up 47 months). Six patients (18%) underwent secondary surgery because of an increase in tumor size or dilation of the main pancreatic duct; 3 of them had lymph node metastasis in the resected specimen. Surgery was followed by pancreatic fistula in 2/6 patients, 1 of whom died. Fourteen patients (mean age 59 years, 64.3% female, mean size of lesions 11.4±3.1 mm) underwent pancreatic surgery immediately after diagnosis. The surgery-associated complication rate was 57.1% (8/14). Of the 14 patients, 13 remained recurrence free (mean follow up 67 months). Recurrent metastatic disease was observed 3 years after pancreaticoduodenectomy (R0, 15 mm G2 lesion, 0 N+/8 N) in 1 patient. Conclusions: The behavior of small nf pNETs is difficult to predict, as there is evidence for malignant behavior in a subgroup of patients, even after surgical treatment. Optimal management remains challenging, as pancreatic surgery is associated with significant morbidity. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

20. Benefit of radiofrequency ablation after widespread endoscopic resection of neoplastic Barrett’s esophagus in daily practice

Author

Godat, Sébastien, Marx, Mariola, Caillol, Fabrice, Robert, Maxime, Autret, Aurélie, Bories, Erwan, Pesenti, Christian, Ratone, Jean Philippe, Schoepfer, Alain, Poizat, Flora, and Giovannini, Marc

Subjects
high-grade dysplasia, surgical procedures, operative, endoscopic resection, Gastroenterology, Barrett’s esophagus, Original Article, esophageal cancer, radiofrequency ablation
Abstract

Background High-grade dysplasia (HGD) and intramucosal carcinoma (IMC) in Barrett’s esophagus (BE) are now well-established indications for endoscopic resection (ER). Radiofrequency ablation (RFA) can be combined with ER in case of flat or long-segment BE ablation. We report here our experience of complementary RFA after widespread ER of neoplastic BE in daily practice. Method We retrospectively reviewed data of 89 patients, treated between 2006 and 2013 by ER alone (group 1) or by ER combined with RFA (group 2). Results Fifty-five patients in group 1 (7F/48M, mean age 68 years) underwent widespread ER with eradication of residual non-dysplastic BE. Complete eradication of HGD/IMC and intestinal metaplasia (IM) was achieved in 32/32 (100%) and 48/55 (87.3%) patients, respectively. Thirty-four patients in group 2 (3F/31M, mean age 67 years) had a multimodal treatment strategy, with widespread ER followed by RFA. Mean Prague classification of BE in this group was significantly longer (C4.4M6.6 vs. C2.7M4.5, P

Published
2021

22. Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study

Author

Rochigneux, Philippe, primary, Tyran, Marguerite, additional, Autret, Aurélie, additional, Lopez Almeida, Leonor, additional, Guiramand, Jérôme, additional, Ferre, Marjorie, additional, Chanez, Brice, additional, Mitry, Emmanuel, additional, Ratone, Jean Philippe, additional, Giovannini, Marc, additional, Tallet, Agnès, additional, Moureau-Zabotto, Laurence, additional, and Caillol, Fabrice, additional

Published
2022
Full Text
View/download PDF

25. Correction: Efficiency of an endoscopic resection strategy in the management of submucosal tumors less than 20 mm in size and located in the upper gastrointestina

Author

Caillol, Fabrice, additional, Meunier, Elise, additional, Zemmour, Cristophe, additional, Ratone, Jean-Philippe, additional, Guiramand, Jerome, additional, Pesenti, Christian, additional, Hoibian, Solene, additional, Dahel, Yanis, additional, Marx, Mariola, additional, Poizat, Florat, additional, and Giovannini, Marc, additional

Published
2022
Full Text
View/download PDF

27. 260 GASTRIC PERORAL ENDOSCOPY PYLOROMYOTOMY (G-POEM) FOR MANAGING REFRACTORY GASTROPARESIS CONSECUTIVE TO ESOPHAGEAL RESECTION: RESULTS FROM MULTICENTER SERIES

Author

Silete, Pierre-Jean, Hugova, Kristina, Degand, Thibault, Houzvickova, Magdalena, Caillol, Fabrice, Ratone, Jean Philippe, Pioche, Mathieu, Rivory, Jerome, Vanbiervliet, Geoffroy, Leblanc, Sarah, Lépilliez, Dr Vincent, Debourdeau, Antoine, Caillo, Ludovic, Koch, Stéphane, Godat, Sebastien, Barthet, Marc, Martinek, Jan, and Gonzalez, Jean-Michel

Published
2024
Full Text
View/download PDF

28. Management of non‐functional pancreatic neuroendocrine tumors by endoscopic ultrasound‐guided radiofrequency ablation: Retrospective study in two tertiary centers

Author

Marx, Mariola, primary, Godat, Sébastien, additional, Caillol, Fabrice, additional, Poizat, Flora, additional, Ratone, Jean‐Philippe, additional, Pesenti, Christian, additional, Schoepfer, Alain, additional, Hoibian, Solène, additional, Dahel, Yanis, additional, and Giovannini, Marc, additional

Published
2022
Full Text
View/download PDF

30. EUS-guided hepaticogastrostomy in patients with obstructive jaundice after failed or impossible endoscopic retrograde drainage: A multicenter, randomized phase II Study

Author

Marx, Mariola, primary, Caillol, Fabrice, additional, Autret, Aurélie, additional, Ratone, Jean-Philippe, additional, Zemmour, Christophe, additional, Boher, JeanMarie, additional, Pesenti, Christian, additional, Bories, Erwan, additional, Barthet, Marc, additional, Napoléon, Bertrand, additional, and Giovannini, Marc, additional

Published
2022
Full Text
View/download PDF

32. Endoscopic Ultrasound-Guided Radiofrequency Ablation as an Future Alternative to Pancreatectomy for Pancreatic Metastases from Renal Cell Carcinoma: A Prospective Study

Author

Chanez, Brice, primary, Caillol, Fabrice, additional, Ratone, Jean-Philippe, additional, Pesenti, Christian, additional, Rochigneux, Philippe, additional, Pignot, Géraldine, additional, Thomassin, Jeanne, additional, Brunelle, Serge, additional, Walz, Jochen, additional, Salem, Naji, additional, Giovannini, Marc, additional, and Gravis, Gwenaelle, additional

Published
2021
Full Text
View/download PDF

33. Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review

Author

Rony, Maelle, primary, Ratone, Jean-Philippe, additional, Walz, Jochen, additional, Pignot, Geraldine, additional, Caillol, Fabrice, additional, Pesenti, Christian, additional, Guerin, Mathilde, additional, Dermeche, Slimane, additional, Brunelle, Serge, additional, Salem, Naji, additional, Vicier, Cecile, additional, Rybikowski, Stanislas, additional, Maubon, Thomas, additional, Fakhfakh, Sami, additional, Tejeda, Manuel, additional, Giovannini, Marc, additional, and Gravis, Gwenaelle, additional

Published
2021
Full Text
View/download PDF

34. Place et évolution de la ponction sous écho-endoscopie à visée diagnostique en 2022.

Author

Ratone, Jean-Philippe, Poizat, Flora, Caillol, Fabrice, and Giovannini, Marc

Subjects
*NEEDLE biopsy, *ENDOSCOPIC ultrasonography, *CELLULAR pathology
Abstract

Résumé: En 2022, la ponction sous écho-endoscopie à l'aide d'un écho-endoscope linéaire est une des indications principales de l'écho-endoscopie diagnostique. Elle est la pierre angulaire de la prise en charge des masses pancréatiques solides, mais également d'autres lésions péri-digestives (lésions kystiques, GIST, etc.). Les aiguilles cytologiques, sûres et efficaces avec une sensibilité supérieure à 85 % et une spécificité supérieure à 95 %, sont supplantées par le développement des aiguilles histologiques « nouvelle génération » permettant d'obtenir un matériel histologique de meilleure qualité sans majorer la morbidité. Ces évolutions adaptées à la médecine de plus en plus personnalisée et guidée par les marqueurs théranostiques ont progressivement changé la technique, en particulier la gestion de l'anatomo-pathologie. In 2022, EUS-guided sampling with linear EUS scope is one of the main diagnosis EUS indication. EUS-guided sampling is the building block concerning management of pancreatic solid mass but also other peridigestive lesions (cystic lesion, GIST, etc.). EUS fine needle aspiration (EUS-FNA), safe and efficient with sensibility over 85% and specificity over 95%, is gradually supplanted by EUS fine needle biopsy (EUS-FNB) which allows better histological materiel acquisition without increasing morbidity. These evolutions, perfectly adapted to modern medicine (personalized with theranostic markers) changed the EUS usage in particular cytopathology management. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

35. Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review

Author

Rony, Maelle, primary, Ratone, Jean-Philippe, additional, Walz, Jochen, additional, Pignot, Geraldine, additional, Caillol, Fabrice, additional, Pesenti, Christian, additional, Guerin, Mathilde, additional, Dermeche, Slimane, additional, Brunelle, Serge, additional, Salem, Naji, additional, Vicier, Cecile, additional, Rybikowski, Stanislas, additional, Maubon, Thomas, additional, Fakhfakh, Sami, additional, Tejeda, Manuel, additional, Giovannini, Marc, additional, and Gravis, Gwenaelle, additional

Published
2021
Full Text
View/download PDF

36. Preoperative EUS evaluation of the response to neoadjuvant therapy for gastric and esophagogastric junction cancer is correlated with survival: A single retrospective study of 97 patients

Author

Hoibian, Solène, primary, Giovannini, Marc, additional, Autret, Aurélie, additional, Pesenti, Christian, additional, Bories, Erwan, additional, Ratone, Jean-Philippe, additional, Dahel, Yanis, additional, Dermeche, Slimane, additional, Meillat, Hélène, additional, Guiramand, Jérôme, additional, and Caillol, Fabrice, additional

Published
2021
Full Text
View/download PDF

38. Endoscopic management of concomitant biliary and duodenal malignant obstruction: Impact of the timing of drainage for one vs. two procedures and the modalities of biliary drainage

Author

Debourdeau, Antoine, primary, Caillol, Fabrice, additional, Zemmour, Christophe, additional, Winkler, JéromePolypo, additional, Decoster, Claire, additional, Pesenti, Christian, additional, Ratone, Jean-Philippe, additional, Boher, JeanMarie, additional, and Giovannini, Marc, additional

Published
2021
Full Text
View/download PDF

40. Is Piecemeal Endoscopic Resection Acceptable for Early Colorectal Cancers in Certain Situations? A Single-Center French Study

Author

Ratone, Jean-Philippe, primary, Caillol, Fabrice, primary, Zemmour, Christophe, primary, Bories, Erwan, primary, Pesenti, Christian, primary, Godat, Sébastien, primary, Hoibian, Solene, primary, De Chaisemartin, Cécile, primary, Meillat, Hélène, primary, Lelong, Bernard, primary, Poizat, Flora, primary, and Giovannini, Marc, primary

Published
2020
Full Text
View/download PDF

42. Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection

Author

Forté, Emmanuel, additional, Petit, Bérénice, additional, Walter, Thomas, additional, Lépilliez, Vincent, additional, Vanbiervliet, Geoffroy, additional, Rostain, Florian, additional, Barsic, Neven, additional, Albeniz, Eduardo, additional, Gete, Gonzalo Gonzalez, additional, Gabriel, Jose Carlos Marín, additional, Cuadrado-Tiemblo, Cristina, additional, Ratone, Jean-Philippe, additional, Jacques, Jérémie, additional, Wallenhorst, Timothée, additional, Subtil, Fabien, additional, Albouys, Jérémie, additional, Giovannini, Marc, additional, Chaussade, Stanislas, additional, Landel, Véréna, additional, Ponchon, Thierry, additional, Saurin, Jean-Christophe, additional, Barret, Maximilien, additional, and Pioche, Mathieu, additional

Published
2020
Full Text
View/download PDF

43. Endoscopic Ultra Sound-guided RadioFrequency Ablation (EUSRFA) as focal treatment for pancreatic metastases from renal cell carcinoma: A monocentric experience.

Author

Chanez, Brice, primary, Caillol, Fabrice, additional, Ratone, Jean-Philippe, additional, Bories, Erwan, additional, Pesenti, Christian, additional, Pignot, Geraldine, additional, Brunelle, Serge, additional, Walz, Jochen, additional, Thomassin, Jeanne, additional, Salem, Naji, additional, Giovannini, Marc, additional, and Gravis, Gwenaelle, additional

Published
2020
Full Text
View/download PDF

44. Benefit of radiofrequency ablation after widespread endoscopic resection of neoplastic Barrett’s esophagus in daily practice.

Author

Godat, Sébastien, Marx, Mariola, Caillol, Fabrice, Robert, Maxime, Autret, Aurélie, Bories, Erwan, Pesenti, Christian, Ratone, Jean Philippe, Schoepfer, Alain, Poizat, Flora, and Giovannini, Marc

Subjects
BARRETT'S esophagus, ENDOSCOPIC surgery, CATHETER ablation, COMBINED modality therapy
Abstract

Background High-grade dysplasia (HGD) and intramucosal carcinoma (IMC) in Barrett’s esophagus (BE) are now well-established indications for endoscopic resection (ER). Radiofrequency ablation (RFA) can be combined with ER in case of flat or long-segment BE ablation. We report here our experience of complementary RFA after widespread ER of neoplastic BE in daily practice. Method We retrospectively reviewed data of 89 patients, treated between 2006 and 2013 by ER alone (group 1) or by ER combined with RFA (group 2). Results Fifty-five patients in group 1 (7F/48M, mean age 68 years) underwent widespread ER with eradication of residual non-dysplastic BE. Complete eradication of HGD/IMC and intestinal metaplasia (IM) was achieved in 32/32 (100%) and 48/55 (87.3%) patients, respectively. Thirty-four patients in group 2 (3F/31M, mean age 67 years) had a multimodal treatment strategy, with widespread ER followed by RFA. Mean Prague classification of BE in this group was significantly longer (C4.4M6.6 vs. C2.7M4.5, P<0.001). Complete eradication of HGD/IMC and non-dysplastic BE was confirmed in 26/27 (96.3%) and 20/34 (58.8%) patients, respectively. There was no significant difference between groups concerning adverse events (16.4% vs. 23.5%, P=0.58) or recurrence rate of HGD/IMC (9.1% vs. 14.7%, P=0.42). The mismatch rate between preoperative and final histological diagnosis was high in both groups, at 45.5% and 26.5%. Conclusions A combination of ER and RFA can treat significantly longer neoplastic BE than ER alone, with the same efficiency and safety. Widespread ER, in contrast, is the only method of obtaining a reliable histological diagnosis. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

48. Endoscopic mucosal resection of sporadic duodenal nonampullary adenoma: outcomes of 130 patients with a long-term follow up in two tertiary French centers.

Author

Hoibian, Solène, Ratone, Jean-Philippe, Gonzalez, Jean-Michel, Bories, Erwan, Pesenti, Christian, Caillol, Fabrice, Grimaud, Jean-Charles, Giovannini, Marc, and Barthet, Marc

Subjects
*ADENOMA, *DUODENAL tumors, *HEMORRHAGE, *ENDOSCOPIC surgery
Abstract

Background The long-term outcomes and safety of endoscopic mucosal resection (EMR) of sporadic duodenal adenoma (SDA), and the management of adverse events need to be confirmed. Methods A bicentric retrospective study was performed including all patients who underwent EMR for SDAs from 2003-2016. The primary aim was to evaluate the efficiency of EMR for SDA. The secondary objectives were to assess safety, recurrence management, predictive factors for treatment success, and adverse events. Results One hundred thirty patients (134 procedures) were included (median age 65 years, 49.3% male). The mean SDA size was 20.7 (range 5-50) mm. Of the SDAs, 58.2% were category 3 of the Vienna classification, 35.8% were category 4, and 5.9% were category 5. The median follow up was 25.0 (range 2-120) months. Complete mucosal resection was achieved for 129/134 lesions (96.2%), with en bloc resection in 59/134 (44%). Recurrence occurred in 28.6% of cases (30/105 procedures). Recurrence was successfully treated by new endoscopic procedures in 72.2% (13/18) and by surgery in 27.8% (5/18). Delayed bleeding occurred in 13.4% of cases (18/134) and was successfully managed endoscopically. The perforation rate was 3.7% (5/134); perforations were managed without surgery in 60% (3/5 patients) of cases. Conclusions Endoscopic treatment of SDA appears to be effective and relatively safe in tertiary centers. All bleeding complications were endoscopically controlled, and perforation was rare. Recurrence was frequent but could be managed endoscopically. EMR is confirmed as a first-line treatment in cases of SDA, and surgery is useful only if repeated EMRs fail. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

49. Efficacy and safety of endoscopic radiofrequency ablation for metastatic pancreatic renal cell carcinoma: A monocentric experience.

Author

Gravis, Gwenaelle, primary, Chanez, Brice, additional, Walz, Jochen, additional, Ratone, Jean-Philippe, additional, Pignot, Geraldine, additional, Pesenti, Christian, additional, Thomassin, Jeanne, additional, Caillol, Fabrice, additional, Brunelle, Serge, additional, Salem, Naji, additional, Bories, Erwan, additional, and Giovannini, Marc, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results